Progressive Supranuclear Palsy (PSP) Recruiting Phase 3 Trials for Rivastigmine (DB00989)

Also known as: Progressive Supranuclear Palsy / Steele-Richardson-Olszewski syndrome / Supranuclear Palsy, Progressive

IndicationStatusPhase
DBCOND0063930 (Progressive Supranuclear Palsy (PSP))Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02839642Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear PalsyTreatment